Ionis Pharmaceuticals, Inc. (IONS)

Oncology Corporate Profile

Stock Performance

59.8000
2.0700

3 Month Stock History Chart

HQ Location

2855 Gazelle Court
Carlsbad, CA 92010

Company Description

Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using its proprietary antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over three dozen drugs in development.

Website: http://www.ionispharma.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
AZD9150 (+ MEDI4736)antisense drugDiffuse large B-cell Lymphoma (DLBCL)IIAstraZeneca
AZD9150 (+ MEDI4736)antisense drugHead & Neck cancerIIAstraZeneca
AZD5312antisense drugProstate cancerIIAstraZeneca
apatorsen / OGX-427antisense drugVarious cancer typesIIOncoGenex

Source: http://www.ionispharma.com/

Recent News Headlines

There are no news items to display